GLAXOSMITHKLINE
GLAXOSMITHKLINE
Aktie · GB0009252882 · 940561 (XLON)
Übersicht Finanzkennzahlen
15,12 GBP
-0,26 % -0,04 GBP
Schlusskurs XLON 06.06.2025: 1.511,50 GBX
London (XLON) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 15:14

Aktuelle Kurse von GLAXOSMITHKLINE

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XLON: London
London
GSK.L
GBX
06.06.2025 15:14
1.511,50 GBX
1.510,00 GBX
+0,10 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 2,15 % 4,39 % 0,53 % 12,06 % -7,21 % -8,62 %

Firmenprofil zu GLAXOSMITHKLINE Aktie

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Investierte Fonds

Folgende Fonds haben in investiert: GLAXOSMITHKLINE investiert:

Fonds
iShares STOXX Europe Select Dividend 30 UCITS ETF (DE)
Vol. in Mio
26.710,97
Anteil (%)
6,20 %
Fonds
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in Mio
2.672,42
Anteil (%)
6,12 %
Fonds
iShares MSCI Europe Quality Dividend UCITS ETF
Vol. in Mio
3.588,40
Anteil (%)
4,21 %
Fonds
iShares MSCI UK UCITS ETF GBP (Acc)
Vol. in Mio
4.967,85
Anteil (%)
4,03 %
Fonds
iShares Core FTSE 100 UCITS ETF GBP (Acc)
Vol. in Mio
63.663,50
Anteil (%)
3,69 %

Unternehmensdaten

Name GLAXOSMITHKLINE
Firma GSK plc
Website https://www.gsk.com
Heimatbörse XLON London
WKN 940561
ISIN GB0009252882
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Ms. Emma Natasha Walmsley
Marktkapitalisierung 54 Mrd.
Land Großbritannien und Nordirland
Währung GBP
Mitarbeiter 68,6 T
Adresse 980 Great West Road, TW8 9GS Brentford
IPO Datum 1988-07-01
Dividenden von 'GLAXOSMITHKLINE'
Ex-Datum Dividende pro Aktie
15.05.2025 16,00 GBX
20.02.2025 16,00 GBX
14.11.2024 15,00 GBX
15.08.2024 15,00 GBX
16.05.2024 15,00 GBX
22.02.2024 16,00 GBX
16.11.2023 14,00 GBX
17.08.2023 14,00 GBX
18.05.2023 14,00 GBX
23.02.2023 13,75 GBX

Aktien-Splits

Datum Split
19.07.2022 4:5
28.10.1991 2:1
24.11.1989 2:1

Ticker Symbole

Name Symbol
London GSK.L

Weitere Aktien

Investoren die GLAXOSMITHKLINE die halten, haben auch folgende Aktien im Depot:
AMAZON.CO INC
AMAZON.CO INC Aktie
APPLE INC
APPLE INC Aktie
AT & T INC
AT & T INC Aktie
COCA-COLA CO
COCA-COLA CO Aktie
INSTRUMENT DE000VP969H8
INSTRUMENT DE000VP969H8 Unbekannt
MICROSOFT CORP
MICROSOFT CORP Aktie
MÜNCHENER RÜCK AG
MÜNCHENER RÜCK AG Aktie
Novo Nordisk (alt)
Novo Nordisk (alt) Aktie
RIO TINTO
RIO TINTO Aktie
TENCENT . LTD
TENCENT . LTD Aktie
TJX CO INC20/31
TJX CO INC20/31 Anleihe
TOYOTA M.CRD 25/30 MTN
TOYOTA M.CRD 25/30 MTN Anleihe
UNILEVER PLC
UNILEVER PLC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025